BRCAness in prostate cancer
Open Access
- 29 March 2019
- journal article
- Published by Impact Journals, LLC in Oncotarget
- Vol. 10 (25) , 2421-2422
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Somatic aberrations of BRCA1 gene are associated with ALDH1, EGFR, and tumor progression in prostate cancerInternational Journal of Cancer, 2018
- Minimal functional driver gene heterogeneity among untreated metastasesScience, 2018
- Relevance of poly (ADP-ribose) polymerase inhibitors in prostate cancerCurrent Opinion in Supportive & Palliative Care, 2018
- Summary statement on screening for prostate cancer in EuropeInternational Journal of Cancer, 2017
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk ScoresJournal of Clinical Oncology, 2017
- BRCAness revisitedNature Reviews Cancer, 2016
- Exploring Prostate Cancer Genome Reveals Simultaneous Losses of PTEN, FAS and PAPSS2 in Patients with PSA Recurrence after Radical ProstatectomyInternational Journal of Molecular Sciences, 2015
- BRCA1 Loss Preexisting in Small Subpopulations of Prostate Cancer Is Associated with Advanced Disease and Metastatic Spread to Lymph Nodes and Peripheral BloodClinical Cancer Research, 2010
- Getting to the Root of BRCA1-Deficient Breast CancerCell Stem Cell, 2009
- Asynchronous Growth of Prostate Cancer Is Reflected by Circulating Tumor Cells Delivered from Distinct, Even Small Foci, Harboring Loss of Heterozygosity of the PTEN GeneCancer Research, 2006